Why HIND? Vyome Holdings, Inc. Analysis, Price & AI Insights | Whystock
HIND
$1.96-0.07 (-3.45%)
Market ClosedLast close May 1
Vyome Holdings, Inc., a clinical-stage specialty pharmaceutical company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States.